MX2019007602A - Nanoparticulas recubiertas para su uso para modular la polarizacion electrica de neuronas. - Google Patents
Nanoparticulas recubiertas para su uso para modular la polarizacion electrica de neuronas.Info
- Publication number
- MX2019007602A MX2019007602A MX2019007602A MX2019007602A MX2019007602A MX 2019007602 A MX2019007602 A MX 2019007602A MX 2019007602 A MX2019007602 A MX 2019007602A MX 2019007602 A MX2019007602 A MX 2019007602A MX 2019007602 A MX2019007602 A MX 2019007602A
- Authority
- MX
- Mexico
- Prior art keywords
- nanoparticles
- nanoparticle
- aggregate
- neurons
- transduction
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Social Psychology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere al campo médico, en particular a la modulación de la polarización eléctrica de neuronas. Más específicamente, la presente invención se refiere a una nanopartícula o un agregado de nanopartículas para su uso para modular la polarización eléctrica de neuronas en un sujeto, por ejemplo para su uso en la prevención o el tratamiento de una enfermedad neuronal en un sujeto, normalmente modulando la polarización eléctrica de neuronas en el sujeto, en donde i) cuando la nanopartícula o el agregado de nanopartículas se expone a una fuente de luz, el material de nanopartículas o de agregado de nanopartículas se selecciona de un material que permite transducción optoeléctrica, transducción opto-térmica o transducción opto-óptica, ii) cuando la nanopartícula o el agregado de nanopartículas se expone a un campo magnético, el material de nanopartículas o de agregado de nanopartículas se selecciona de un material que permite transducción magneto-eléctrica o transducción magnetotérmica, iii) cuando la superficie de la nanopartícula o del agregado de nanopartículas se expone a una fuente de ultrasonidos, el material de nanopartículas o de agregado de nanopartículas es un material que permite transducción acustico-eléctrica, y en donde la nanopartícula o el agregado de nanopartículas o bien se carga de forma neutra en ausencia de cualquier recubrimiento o bien se recubre con un agente hidrófilo que confiere una carga superficial neutra a la nanopartícula o el agregado de nanopartículas. Se refiere además a composiciones y kits que comprenden dichas nanopartículas y/o agregados de nanopartículas, así como a usos de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16306753 | 2016-12-21 | ||
| PCT/EP2017/083658 WO2018115023A1 (en) | 2016-12-21 | 2017-12-19 | Coated nanoparticles for use for modulating electrical polarization of neurons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019007602A true MX2019007602A (es) | 2019-08-16 |
Family
ID=57868007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019007602A MX2019007602A (es) | 2016-12-21 | 2017-12-19 | Nanoparticulas recubiertas para su uso para modular la polarizacion electrica de neuronas. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11229705B2 (es) |
| EP (1) | EP3558372A1 (es) |
| JP (1) | JP2020502220A (es) |
| KR (1) | KR20190107027A (es) |
| CN (1) | CN110520159A (es) |
| AU (1) | AU2017384538A1 (es) |
| BR (1) | BR112019012999A2 (es) |
| CA (1) | CA3048469A1 (es) |
| EA (1) | EA039081B1 (es) |
| IL (1) | IL267405B2 (es) |
| MX (1) | MX2019007602A (es) |
| WO (1) | WO2018115023A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018114988A1 (en) | 2016-12-21 | 2018-06-28 | Nanobiotix | Nanoparticles for use for enhancing brain performances or for treating stress |
| KR20190105592A (ko) | 2016-12-21 | 2019-09-17 | 나노비오?스 | 뉴런 장애의 치료에 사용하기 위한 나노입자 |
| KR20200110321A (ko) | 2017-12-19 | 2020-09-23 | 나노비오띡스 | 신경 장애의 치료에서 사용하기 위한 나노입자 |
| US11471482B2 (en) | 2017-12-19 | 2022-10-18 | Nanobiotix S.A. | Nanoparticles for use in enhancing brain performances or in treating stress |
| CN108853057B (zh) * | 2018-07-03 | 2019-11-12 | 东南大学 | 超顺磁性氧化铁纳米颗粒在制备用于治疗神经性疾病的神经磁刺激增强剂中的应用 |
| CN109125728A (zh) * | 2018-10-24 | 2019-01-04 | 东南大学 | 基于细胞载药技术控制磁性纳米颗粒无创入脑的方法 |
| CN110707324A (zh) * | 2019-10-13 | 2020-01-17 | 浙江大学 | 导电粘结剂的制备及在电池电极中的应用 |
| KR20210113800A (ko) * | 2020-03-09 | 2021-09-17 | 숙명여자대학교산학협력단 | 표적 단백질을 분해하는 방법 및 장치 |
| KR20220067684A (ko) * | 2020-11-18 | 2022-05-25 | 재단법인대구경북과학기술원 | 자성-압전 마이크로 로봇 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100620615B1 (ko) | 2005-05-23 | 2006-09-06 | 한국생명공학연구원 | 가시광선 영역의 색을 갖는 금속 나노입자 혼합물이 코팅된 다색 콜로이드 입자 및 그 제조방법 |
| GB201121288D0 (en) * | 2011-12-12 | 2012-01-25 | Univ Muenster Wilhelms | Functionalised silicon nanoparticles |
| AU2013237874B2 (en) * | 2012-03-29 | 2018-01-18 | Translate Bio, Inc. | Lipid-derived neutral nanoparticles |
| US9272158B2 (en) * | 2012-05-22 | 2016-03-01 | The Florida International University Board Of Trustees | Method for non-invasive brain stimulation |
| US9242087B2 (en) | 2012-06-01 | 2016-01-26 | The Regents Of The University Of Michigan | Nanocomposites for neural prosthetics devices |
| CN104548128A (zh) * | 2015-01-28 | 2015-04-29 | 苏州大学 | 一种基于荧光硅纳米颗粒的药物载体的制备方法 |
| US10285934B1 (en) * | 2015-11-01 | 2019-05-14 | Battelle Memorial Institute | Administration of a drug through the blood brain barrier using stimuli-responsive nanoparticles |
| WO2018114988A1 (en) | 2016-12-21 | 2018-06-28 | Nanobiotix | Nanoparticles for use for enhancing brain performances or for treating stress |
| KR20190105592A (ko) | 2016-12-21 | 2019-09-17 | 나노비오?스 | 뉴런 장애의 치료에 사용하기 위한 나노입자 |
-
2017
- 2017-12-19 AU AU2017384538A patent/AU2017384538A1/en not_active Abandoned
- 2017-12-19 CN CN201780085559.0A patent/CN110520159A/zh active Pending
- 2017-12-19 EP EP17821615.6A patent/EP3558372A1/en active Pending
- 2017-12-19 CA CA3048469A patent/CA3048469A1/en active Pending
- 2017-12-19 BR BR112019012999A patent/BR112019012999A2/pt not_active IP Right Cessation
- 2017-12-19 JP JP2019533601A patent/JP2020502220A/ja active Pending
- 2017-12-19 MX MX2019007602A patent/MX2019007602A/es unknown
- 2017-12-19 US US16/472,216 patent/US11229705B2/en active Active
- 2017-12-19 KR KR1020197020850A patent/KR20190107027A/ko not_active Application Discontinuation
- 2017-12-19 EA EA201991522A patent/EA039081B1/ru unknown
- 2017-12-19 WO PCT/EP2017/083658 patent/WO2018115023A1/en unknown
-
2019
- 2019-06-16 IL IL267405A patent/IL267405B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018115023A1 (en) | 2018-06-28 |
| KR20190107027A (ko) | 2019-09-18 |
| US11229705B2 (en) | 2022-01-25 |
| JP2020502220A (ja) | 2020-01-23 |
| CN110520159A (zh) | 2019-11-29 |
| CA3048469A1 (en) | 2018-06-28 |
| IL267405B (en) | 2022-10-01 |
| AU2017384538A1 (en) | 2019-08-01 |
| BR112019012999A2 (pt) | 2019-12-10 |
| US20190351057A1 (en) | 2019-11-21 |
| EA039081B1 (ru) | 2021-12-01 |
| IL267405B2 (en) | 2023-02-01 |
| IL267405A (en) | 2019-08-29 |
| EP3558372A1 (en) | 2019-10-30 |
| EA201991522A1 (ru) | 2019-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019007602A (es) | Nanoparticulas recubiertas para su uso para modular la polarizacion electrica de neuronas. | |
| MX2019007607A (es) | Nanoparticulas para su uso para potenciar rendimientos del cerebro o para tratar estres. | |
| MX2023000745A (es) | Composiciones para usarse en el suministro de agentes biomacromoleculares. | |
| MX2019007614A (es) | Nanoparticulas para su uso para tratar un trastorno neuronal. | |
| WO2018026722A8 (en) | COMPOSITIONS AND METHODS FOR INHIBITING MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS | |
| NZ711598A (en) | Substituted naphthyridine and quinoline compounds as mao inhibitors | |
| EA201190303A1 (ru) | ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-а]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДУПРЕЖДЕНИЯ НЕВРОЛОГИЧЕСКИХ И ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ | |
| MX2016008110A (es) | Derivados de pirazol como inhibidores de la cinasa de cremallera de leucina dual (dlk) y usos de los mismos. | |
| MX2015009270A (es) | Pirazoles sustituidos en posicion 3 y uso de los mismos como inhibidores de la cinasa cremallera de leucinas dual (dlk). | |
| EA201590709A1 (ru) | Комбинированная терапия и ее применение для лечения димиелинизирующих расстройств | |
| WO2016007629A3 (en) | Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations | |
| EA201391379A1 (ru) | Фармацевтическая композиция для лечения заболевания в полости рта, содержащая ребамипид | |
| AU2018243836A1 (en) | Gut-selective sequestering agents for the treatment and prevention of autism and related disorders | |
| WO2021022163A3 (en) | Compounds and uses thereof | |
| MX2022012474A (es) | Compuestos y usos de estos. | |
| MX2016015556A (es) | Pigmentos de efecto. | |
| ZA202207804B (en) | Compounds and uses thereof | |
| MX2022009369A (es) | Compuestos y usos de estos. | |
| WO2022109396A8 (en) | Compounds and uses thereof | |
| MX2022009308A (es) | Compuestos y usos de estos. | |
| EA201692496A1 (ru) | 6,7-ДИГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИН-4(5H)-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ОТРИЦАТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ MGLUR2 | |
| PH12020551779A1 (en) | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | |
| MX2023005436A (es) | Compuestos y usos de estos. | |
| ZA202004343B (en) | Nanoparticles for use in enhancing brain performances or in treating stress | |
| MX2015015952A (es) | Composicion que comprende una combinacion de un polimero acrilico y un copolimero de silicona y un aminoacido o un derivado de aminoacido. |